N. Rajendiran et al. / Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 123 (2014) 158–166
159
flasks. To this, varying concentration of CD solution (1.0 ꢁ 10ꢂ3
to 1.0 ꢁ 10ꢂ2 M) was added. The mixed solution was diluted to
10 ml with triply distilled water and shaken thoroughly. The final
concentration of SMP in all the flasks was 4 ꢁ 10ꢂ5 M. The experi-
ments were carried out at room temperature at 300 K.
O
H
N
N
N
H3C
O
S
NH2
O
Fig. 1. Chemical structure of SMP.
Instruments
splendid evolution because of its potential ability in a diverse
range of applications. These inclusion complexes can serve as min-
iature models for studying the mode of action of enzymes [12]
mimicking the reactions in biosystems [13] and so forth. These,
have promising prospects in future applications like drug delivery
[14], nanometer-sized electronic devices, and development of en-
ergy storage devices [15]. In this article, we report the fabrication
of 2D nanosheet through self assembly of b-cyclodextrin with sul-
famethoxypyridazine (Fig. 1) drug. The self assembled morphology
was observed using transmission electron microscope (TEM) and
scanning electron microscope (SEM). We proposed a reasonable
formation mechanism for the formation of the 2D nanosheet. The
inclusion complexes were subsequently characterized by FT-IR,
differential scanning calorimeter (DSC), powder X-ray diffraction
(PXRD), 1H NMR, absorption and fluorescence emission spectros-
copy techniques. The sulfamethoxypyridazine (SMP) belongs to a
class of sulfonamide drugs, which is frequently used in pharmaceu-
tical preparation, especially in veterinary practices. Interest in the
field of drug studies are not only for gaining some fundamental in-
sight into the determination of pharmaceutical samples, but also
obtaining information about the structure as well as the cheating
behavior of the drugs.
Scanning electron microscopy (SEM) photographs were col-
lected on a JEOL JSM 5610LV instrument. Morphology of the SMP
inclusion complexes was investigated by transmission electron
microscopy (TEM) using a TECNAI G2 microscope with accelerating
voltage 200 kV. Carbon coated copper TEM grid (200 mesh) was
used for TEM analysis. FT-IR spectra of SMP,
a-CD, b-CD and the
inclusion complexes were recorded 4000–400 cmꢂ1 on Nicolet
Avatar 360 FT-IR spectrometer. 1H NMR spectra for SMP and its
inclusion complexes were recorded on
a Bruker AVANCE
400 MHz spectrometer using DMSO-d6 as a solvent. The differen-
tial scanning calorimeter (DSC) was recorded using Mettler Toledo
DSC1 fitted with STRe software (Mettler Toledo, Switzerland). The
temperature scanning range was from 25 to 220 °C with a heating
rate of 10 °C/min. Powder X-ray diffraction (PXRD) spectra were
recorded with a BRUKER D8 advance diffractometer (Bruker AXS
GmbH, Karlsruhe, Germany), The XRD patterns were measured in
the 2h angle range between 5° and 80° with a scan rate 5°/min.
Absorption spectral measurements were carried out with a Shima-
dzu (model UV 1650 PC) UV–visible spectrophotometer and stea-
dy-state fluorescence measurements were made by using
a
Shimadzu spectrofluorimeter (model RF-5301). The fluorescence
lifetime measurements were performed using a picosecond laser
and single photon counting setup from Jobin-Vyon IBH.
The aim of the present work was to study the self assembly
behavior of SMP drug (Fig. 1) with a-CD and b-CD. The absorption
and fluorescence characteristics of few sulfa drugs with different
solvents, pH and b-CD were already reported [16,17]. In our previ-
ous study we investigated inclusion complexation of some sulfon-
amide derivatives with b-CD. In the present work, we prepared
Molecular modeling studies
The theoretical calculations were performed with Gaussian
solid inclusion complexes of the SMP drug with
a-CD and b-CD
03W package. The initial geometry of the SMP, a-CD and b-CD
and the inclusion complexation behavior was characterized by
UV–visible, fluorescence, life time, FTIR, DSC, PXRD, 1H NMR, SEM
and TEM and techniques.
was constructed with the aid of Spartan 08 and then optimized
by the semiempirical PM3 method at vacuum. The CD was fully
optimized by PM3 without any symmetry constraint [18]. The gly-
cosidic oxygen atoms of CD were placed onto the XY plane and
their center was defined as the center of the coordinate system.
The primary hydroxyl groups were placed pointing toward the po-
sitive Z axis. The inclusion complex was constructed from the PM3
optimized CD and guest molecules. The longest dimension of the
guest molecule was initially placed onto the Z axis. The position
of the guest was determined by the Z coordinate of one selected
atom of the guest. The inclusion process was simulated by putting
the guest on one end of the CD and then letting it pass through the
CD cavities. Since the semiempirical PM3 method has been proved
to be a powerful tool in the conformational study of CD inclusion
complexes and has high computational efficiency [19], we selected
semiempirical PM3 method to study the inclusion process of CDs
with the SMP drug.
Experimental section
Materials
SMP, a-CD and b-CD was purchased from Sigma–Aldrich chem-
ical company and used without further purification. The purity of
the compound was checked for similar fluorescence spectra when
excited with different wavelengths.
Preparation of nanomaterials
CD (1 mmol) was dissolved in 30 ml distilled water and SMP
(1 mmol) in 20 ml methanol and was slowly added to the CD solu-
tion. This solution was stirred at 50 °C overnight. The above solu-
tion was refrigerated overnight at 5 °C. The precipitated SMP/CD
complexes were recovered by filtration and washed with a small
amount of ethanol and water to remove uncomplexed drug and
CD, respectively. This precipitate was dried in vacuum at room
temperature for two days and stored in an airtight bottle. This
powder sample was used for further analysis.
Results and discussion
Micromorphological observations
The surface morphology of powder samples of SMP,
SMP/ -CD and SMP/b-CD complexes were assessed by SEM. As
illustrated in Fig. 2 SMP existed in a microcrystalline structure,
whereas SMP/ -CD inclusion complex appeared in the form of
irregular particles in which the original morphology of both the
SMP and -CD components disappeared and tiny aggregates of
amorphous pieces of irregular shape were present. The SMP/b-CD
a-CD, b-CD,
a
Preparation of CD solution
a
The concentration of stock solution of the drug was 2 ꢁ 10ꢂ3 M.
a
The stock solution (0.2 ml) was transferred into 10 ml volumetric